# Dragonfly-M Early Feasibility Study

> **NCT04528576** · NA · UNKNOWN · sponsor: **Hangzhou Valgen Medtech Co., Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** Dragonfly mitral valve repair system

## Key facts

- **NCT ID:** NCT04528576
- **Lead sponsor:** Hangzhou Valgen Medtech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-23
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528576, "Dragonfly-M Early Feasibility Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04528576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*